CISH and hematopoietic and lymphoid cell neoplasm: We indeed found that regulatory CIS targets (n = 149 genes) were highly significantly enriched for GWAS-associated human cancer variants (p = 0.001, pan-cancer variants; p = 2.98 × 10−6 hematopoietic cancer variants; χ2 test; Table S10).